iifl-logo-icon 1

Senores Pharmaceuticals Ltd Half Yearly Results

568.25
(-4.22%)
Mar 7, 2025|03:31:01 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Sept-2024Mar-2024Sept-2023

Gross Sales

181.02

181.14

33.38

Excise Duty

0

0

0

Net Sales

181.02

181.14

33.38

Other Operating Income

0

0

0

Other Income

2.33

2.76

0.06

Total Income

183.35

183.9

33.44

Total Expenditure

136.45

143.6

29.32

PBIDT

46.9

40.3

4.12

Interest

10.09

5.48

3.97

PBDT

36.81

34.82

0.15

Depreciation

7.41

6.96

3.06

Minority Interest Before NP

0

0

0

Tax

2.73

8.64

-0.64

Deferred Tax

2.73

-2.07

-13.69

Reported Profit After Tax

23.94

21.29

11.42

Minority Interest After NP

0.39

-1.74

3

Net Profit after Minority Interest

23.55

23.03

8.42

Extra-ordinary Items

0

0

0

Adjusted Profit After Extra-ordinary item

23.55

23.03

8.42

EPS (Unit Curr.)

5.11

7.55

2.81

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

46.05

30.51

29.95

Public Shareholding (Number)

0

0

0

Public Shareholding (%)

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

25.9

22.24

12.34

PBDTM(%)

-

-

-

PATM(%)

13.22

11.75

34.21

Senores Pharmaceuticals Ltd: Related NEWS

Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma
5 Mar 2025|11:05 AM

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

Read More
Senores Stock Dips from High, Remains Above IPO Price
30 Dec 2024|04:08 PM

Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.